Erratum: Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis

An erratum on: Srivastava S, Thomas T, Howe D, Malinga L, Raj P, Alffenaar J-W and Gumbo T (2021) Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis. Front. Pharmacol. 12:677005. doi: 10.3389/fphar.2021.677005Due to production error, an existing conflict of interest between one of the reviewers and the authors was not declared. The updated Conflict of Interest statement has been included below. The publisher apologizes for this mistake.“Conflict of InterestTG is founder and CEO of Praedicare Inc. DH is an employee of Praedicare Inc.The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.The reviewer JGP declared past co-authorships with several of the authors, SS, TT, LM, PR, J-WA, and TG, and states that the process nevertheless met the standards of a fair and objective review.”The original version of this article has been updated.